Reply to the article 'Editorial comments on 'reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study'', by P. A. Bunn Jr (Ann Oncol 2001; 12: 1339-1340)
| Autor: | V.C. Tjan-Heijnen, Pe Postmus, Andrea Ardizzoni |
|---|---|
| Rok vydání: | 2002 |
| Předmět: |
medicine.medical_specialty
Lung Neoplasms Neutropenia Fever Placebo Gastroenterology Double blind Experimental diagnostics and therapy of malignancies Chemotherapy induced Double-Blind Method Ciprofloxacin Internal medicine Antineoplastic Combined Chemotherapy Protocols Medicine Humans Carcinoma Small Cell Cyclophosphamide Etoposide Randomized Controlled Trials as Topic Roxithromycin Febrile leucopenia business.industry Palliative Care Hematology Antibiotic Prophylaxis Surgery Oncology Clinical Trials Phase III as Topic Doxorubicin Drug Therapy Combination Non small cell business medicine.drug |
| Zdroj: | Annals of Oncology, 13, 3, pp. 485-486 Annals of Oncology, 13, 485-486 |
| ISSN: | 0923-7534 |
| Popis: | Item does not contain fulltext |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|